, a bio/informatics shared resource is still "open for business" - Visit the CDS website


Dan Roden
Faculty Member
Last active: 3/24/2020

  1. Understanding the use of observational and randomized data in cardiovascular medicine. Bowman L, Baras A, Bombien R, Califf RM, Chen Z, Gale CP, Gaziano JM, Grobbee DE, Maggioni AP, Muse ED, Roden DM, Schroeder S, Wallentin L, Casadei B (2020) Eur Heart J
    › Primary publication · 32016367 (PubMed)
  2. Response by Salem et al to Letter Regarding Article, "Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes". Salem JE, Moslehi JJ, Funck Brentano C, Roden DM (2020) Circulation 141(5): e63-e64
    › Primary publication · 32011925 (PubMed) · PMC7041671 (PubMed Central)
  3. Real-time visualization of titin dynamics reveals extensive reversible photobleaching in human induced pluripotent stem cell-derived cardiomyocytes. Cadar AG, Feaster TK, Bersell KR, Wang L, Hong T, Balsamo JA, Zhang Z, Chun YW, Nam YJ, Gotthardt M, Knollmann BC, Roden DM, Lim CC, Hong CC (2020) Am J Physiol Cell Physiol 318(1): C163-C173
    › Primary publication · 31747312 (PubMed) · PMC6985833 (PubMed Central)
  4. Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease. Mosley JD, Gupta DK, Tan J, Yao J, Wells QS, Shaffer CM, Kundu S, Robinson-Cohen C, Psaty BM, Rich SS, Post WS, Guo X, Rotter JI, Roden DM, Gerszten RE, Wang TJ (2020) JAMA 323(7): 627-635
    › Primary publication · 32068817 (PubMed) · PMC7042849 (PubMed Central)
  5. Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use. Jerome RN, Joly MM, Kennedy N, Shirey-Rice JK, Roden DM, Bernard GR, Holroyd KJ, Denny JC, Pulley JM (2020) Drug Saf 43(6): 567-582
    › Primary publication · 32112228 (PubMed)
  6. Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study. Bretagne M, Lebrun-Vignes B, Pariente A, Shaffer CM, Malouf GG, Dureau P, Potey C, Funck-Brentano C, Roden DM, Moslehi JJ, Salem JE (2020) Arch Cardiovasc Dis 113(1): 9-21
    › Primary publication · 31685432 (PubMed) · PMC7158843 (PubMed Central)
  7. Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation. Shoemaker MB, Husser D, Roselli C, Al Jazairi M, Chrispin J, Kühne M, Neumann B, Knight S, Sun H, Mohanty S, Shaffer C, Thériault S, Rinke LL, Siland JE, Crawford DM, Ueberham L, Zardkoohi O, Büttner P, Geelhoed B, Blum S, Aeschbacher S, Smith JD, Van Wagoner DR, Freudling R, Müller-Nurasyid M, Montgomery J, Yoneda Z, Wells Q, Issa T, Weeke P, Jacobs V, Van Gelder IC, Hindricks G, Barnard J, Calkins H, Darbar D, Michaud G, Kääb S, Ellinor P, Natale A, Chung M, Nazarian S, Cutler MJ, Sinner MF, Conen D, Rienstra M, Bollmann A, Roden DM, Lubitz S (2020) Circ Arrhythm Electrophysiol 13(3): e007676
    › Primary publication · 32078373 (PubMed) · PMC7080569 (PubMed Central)
  8. Development of a System for Postmarketing Population Pharmacokinetic and Pharmacodynamic Studies Using Real-World Data From Electronic Health Records. Choi L, Beck C, McNeer E, Weeks HL, Williams ML, James NT, Niu X, Abou-Khalil BW, Birdwell KA, Roden DM, Stein CM, Bejan CA, Denny JC, Van Driest SL (2020) Clin Pharmacol Ther 107(4): 934-943
    › Primary publication · 31957870 (PubMed) · PMC7093250 (PubMed Central)
  9. Deep Mutational Scan of an Voltage Sensor. Glazer AM, Kroncke BM, Matreyek KA, Yang T, Wada Y, Shields T, Salem JE, Fowler DM, Roden DM (2020) Circ Genom Precis Med 13(1): e002786
    › Primary publication · 31928070 (PubMed) · PMC7031040 (PubMed Central)
  10. CNV Association of Diverse Clinical Phenotypes from eMERGE reveals novel disease biology underlying cardiovascular disease. Glessner JT, Li J, Desai A, Palmer M, Kim D, Lucas AM, Chang X, Connolly JJ, Almoguera B, Harley JB, Jarvik GP, Ritchie MD, Sleiman PMA, Roden DM, Crosslin D, Hakonarson H (2020) Int J Cardiol : 107-113
    › Primary publication · 31447229 (PubMed)